ABSTRACT
Obligatory intracellular bacterium Anaplasma phagocytophilum (Aph) causes an emerging infectious disease called human granulocytic anaplasmosis. Within host cells, Aph proliferates in a membrane-bound vacuole (Aph-vacuole) to which all required nutrients must be routed, including essential iron. Here, using a fluorescent labile iron-binding dye in live image analysis, we found that Aph-vacuoles are enriched with labile iron. Furthermore, ferroportin (Fpn), the only known iron exporter on the plasma membrane of host cells, increasingly encircled the Aph-vacuole post-invasion in a ring-like pattern. Fpn is regulated by the hormone hepcidin, which binds to Fpn and triggers its ubiquitination and internalization, thereby, inhibits iron availability to blood-borne pathogens. Fpn-GFP mutants deficient in ubiquitination (domain deletion or Y64H) did not encircle Aph-vacuoles. Fpn-GFP (D181V) and Fpn-GFP (D39A) mutants that are deficient in iron binding and transport could encircle Aph-vacuoles, but unlike Fpn-GFP (wild-type) did not increase labile iron in Aph-vacuoles or Aph growth. The gene encoding hepcidin is upregulated by inflammation. We found Aph infection induced the expression of the hepcidin mRNA and protein, and strong IL-6, IL-1β, and TNF-α mRNA expression by host cells. Altogether, these results suggest that Aph induces the production of proinflammatory cytokines for the upregulation of hepcidin which triggers the Fpn endocytosis and encasement of Aph-vacuoles in a ubiquitination-dependent manner. Fpn internalization raises host cell cytoplasmic iron and may export iron into the vacuoles to enrich intravacuolar iron for the benefit of bacteria. This finding demonstrates pathogen manipulation of cellular iron export mechanisms and subversion of host hepcidin-Fpn iron nutritional immunity against pathogens.
IMPORTANCE
Iron is an essential element for both humans and microorganisms, serving as a cofactor in key metabolic processes. Obligatory intracellular bacterium Anaplasma phagocytophilum infects and proliferates within a membrane-bound vacuole (Aph-vacuoles) of neutrophils and endothelial cells, competitively acquiring intracellular iron from the host. Upon exploration of cytoplasmic labile free iron levels and distribution in the A. phagocytophilum-infected and uninfected host cells, we uncovered the unique ability of this bacterium to enrich intravacuolar iron. Ferroportin is the only cellular iron exporter of host cells, which is regulated by the hepatic hormone hepcidin. Herein, we investigate the role of ferroportin and endogenous hepcidin locally produced by infected host cells for iron enrichment in Aph-vacuoles. Ultimately, this study provides new insights into the novel mechanisms of microbial manipulation of host cells to acquire the essential micronutrient iron and overcoming host nutritional immunity, which may facilitate more effective treatment and prevention.
KEYWORDS: Anaplasma phagocytophilum, ferroportin, iron transport, hepcidin
INTRODUCTION
Rickettsioses including Anaplasmosis and Ehrlichiosis are among the most deadly vector-borne infectious diseases and greatly increasing in worldwide prevalence (1). Rickettsiae are obligatory intracellular bacteria that infect blood and endothelial cells. Human granulocytic anaplasmosis (HGA), caused by infection with Anaplasma phagocytophilum (Aph), is second in prevalence only to Lyme disease (2, 3), and human monocytic ehrlichiosis (HME), caused by Ehrlichia chaffeensis (Ech), is second in fatality only to Rocky Mountain spotted fever among tick-borne diseases in the US (4). Aph infects and replicates inside granulocytes (2, 5), and Ech infects and replicates inside monocytes-macrophages (6, 7). HGA and HME are severe flu-like febrile diseases accompanied by hematologic abnormalities and signs of hepatitis. There are no FDA-approved vaccines to protect against rickettsial diseases including HGA and HME. The only current therapy for HGA and HME is the broad-spectrum antibiotic doxycycline, which is generally effective with sufficiently early treatment, but no alternatives exist if cases are not treated early, or if microbial resistance develops.
Iron is an essential element for most living organisms, serving as a cofactor in key metabolic processes. As excess iron is toxic, however, systemic and intracellular iron levels are tightly regulated in animals by cellular iron import, storage, and export mechanisms (8, 9). Furthermore, sequestering iron from invading pathogens is an important arm of innate immunity, referred to as nutritional immunity (8, 10, 11). Cellular iron nutritional immunity is exemplified by the divalent cation transporter NRAMP1, that exports Fe2+ from late endosomes/lysosomes, driving resistance to facultative intracellular pathogens that occupy these niches (such as Salmonella, Leishmania, and Mycobacterium) by limiting pathogen growth (12–14). The known systemic iron nutritional immunity is hypoferremia mediated by peptide hormone hepcidin (Hepc, secreted mainly by liver), which not only deprives access to iron to blood-borne pathogens directly but also shapes iron-dependent host cellular pathways that pathogens rely upon or defend against (such as glucose metabolism, oxidative stress, and immune regulation) (15). Infectious stimuli with pathogens induce hepatocytes to produce and secrete Hepc into the blood (16). When systemic Hepc reaches cells, it occludes ferroportin (Fpn), preventing iron export, but also inducing ubiquitination of the intracellular domain, which triggers a Fpn internalization and degradation cascade (17–20). As such, the net iron export is reduced, preventing outgrowth of many invading extracellular pathogens (16, 21, 22). Even though Fpn remains the only known cellular iron exporter of the human host for Aph (23, 24), it’s impact on nutritional immunity to obligate intracellular pathogens like Aph is unknown.
For rickettsiae, iron acquisition is essential, but it is mostly unknown how these bacteria acquire iron from the host intracellular environment, and how they overcome host iron-sequestering nutritional immunity. The labile iron pool (LIP) is the pool of Fe2+ iron in a cell that is not bound to storage or carrier molecules. It is a crucial but transient intermediate in cellular iron metabolism, serving as a source of iron for metabolic processes. While many other bacteria use siderophores, high-affinity iron-chelating compounds that competitively capture iron from the LIP or protein-bound sources (9), all rickettsiae members lack siderophores. For intracellular pathogens Salmonella, Mycobacterium, and Leishmania donovanii, a strategy is to alter iron flow via influencing expression levels and compartmental distribution of iron transporters like NRAMP1, DMT1, and Fpn (25–29). Ech replicates in an early endosome-like compartment (vacuole) that does not fuse with lysosomes (30, 31). We previously discovered Ech acquires iron from two distinct mammalian iron-binding proteins: transferrin (Tf) and ferritin. During initial Ech infection, Tf receptor (TfR) is upregulated and recruits endocytosed iron-laden Tf to the Ech-vacuole (32–34). Upon establishment of infection, secretion of Ech effector Etf-3 induces ferritinophagy, the autophagic liberation of iron from ferritin for bacterial uptake (35).
Aph is closely related to Ech, sharing 98% of protein coding-genes, and it requires iron (36). However, Aph replicates in the membrane-bound compartment, the Aph-vacuole, bearing markers of early autophagosomes and ER-Golgi exit sites and lacking endosome-lysosome markers (30, 31, 37, 38). Aph does not use Ech’s iron-acquisition mechanisms, as unlike Ech, (i) Aph infection does not upregulate TfR mRNA (32); (ii) Aph-containing vacuoles do not acquire Tf or TfR (30); and (iii) Aph lacks Etf-3 orthologs that cause ferritinophagy. We, therefore, investigated Aph iron uptake mechanisms by examining LIP distribution and levels, and host iron transport systems to create wider mechanistic understanding of iron-acquisition strategies used by rickettsial pathogens and enable developing new effective countermeasures.
RESULTS
Labile cellular iron is enriched in Aph-vacuoles, and ferritin is upregulated by Aph infection
Aph infects neutrophils, other granulocytes, and endothelial cells in vivo (39). Monkey endothelial cell line RF/6A is permissive to Aph infection (40) and used for unambiguous cellular localization studies, as they are flat and thinly spread adherent cells (41–43). As Aph replicates in membrane-bound vacuoles, we examined LIP distribution and relative amounts in RF/6A cells by using FerroFarRed probe (35, 44, 45), which is membrane-permeable and fluoresces when N-oxide is selectively deoxygenized by Fe2+ in live cell fluorescence microscopy. Aph vacuoles were defined by the presence of Aph by Hoechst fluorescence which binds bacterial DNA, as membrane permeabilization for immunolabeling of intracellular Aph-vacuoles hinders live image analysis. ImageJ was used to quantitate fluorescence intensity in the area of a defined Region of Interest (ROI) (Fig. S1). The Aph-vacuoles were enriched for LIP (Fig. 1A). This was indicated by the significant enrichment of FerroFarRed fluorescence of the Aph-vacuolar area compared to non-Aph sites in uninfected or infected cells (Fig. 1B). Consequently, relative LIP fluorescence was significantly increased in Aph-infected cells than in uninfected cells (Fig. 1B). The increased LIP may increase intracellular ferritin levels because ferritin stores excess of iron within a cell (46). Ferritin levels were determined by western blot analysis of ferritin light chain (FTL) normalized by human actin, with Aph outer membrane protein P44 (47) as an infected lane control. In Aph-infected HL-60 cells, ferritin was significantly increased compared to uninfected cells (Fig. 1C and D). As described in Introduction, these findings further confirm the distinct nature of Aph-infected cells vs Ech-infected cells, wherein the latter ferritin is diminished due to ferritinophagy (35). Accordingly, enrichment of iron within Aph-vacuoles points to a unique mechanism of Aph infection on iron redistribution and homeostasis within host cells.
Fig 1.
Labile iron pool is enriched in Aph-vacuoles, and cellular ferritin is upregulated in Aph-infected cells. (A) LIP (Labile iron pool, red) detected with FerroFarRed dye in uninfected and Aph-infected RF/6A cells 1 dpi. Live cell image under a Leica Thunder microscope. DNA of nucleus (N) and Aph was stained with Hoechst dye (pseudocolored green). Small green globules indicated by white arrows are Aph-vacuoles. Merge, superimposed fluorescence images. DIC, differential interference contrast. Bar, 10 µm. (B) Scatter plots showing MFI (Mean Fluorescence Intensity) in arbitrary units in individual uninfected and Aph-infected cells, vacuoles, and randomly paired non-vacuole areas (n = 43 cells/group, from which 153 vacuoles were assessed). Visualization of analysis method depicted in Fig. S1. Mean ± SD assessed by Student’s t-test (left graph) or One-Way ANOVA (right graph) where **** indicates P < 0.0001, ns, not significant. (C) Western blot analysis of uninfected (Uninf.) and Aph-infected (Inf. 2 dpi) HL-60 cells with anti-ferritin light chain (FTL), Aph P44, and actin antibodies. (D) Band density ratios of FTL relative to actin. The ratio of uninfected HL-60 cells was arbitrarily set to 1. Mean ± SD where ** indicates significantly different by student’s t-test (P < 0.01). Images and data are representative of three independent experiments.
Fpn-GFP and endogenous Fpn localize on Aph-containing vacuoles
Because Aph-vacuoles were relatively iron dense and elevated LIP levels in infected cells, we hypothesized that infection may change distribution of host iron transport machinery. TfR, a primary mediator of iron import, localizes to Ech-vacuoles, but not to Aph-vacuoles (32), whereas Fpn in the plasma membrane (PM) is the sole cellular Fe2+ exporter for the host, and reduced PM localization of Fpn leads to an increase in LIP in uninfected cells (48). Human promyelocytic leukemia cell line HL-60 is widely used for Aph propagation, and infection studies, but difficult to transfect (2, 49), whereas RF/6A cells have higher transfection efficincy. Therefore, we analyzed intracellular distribution of endogenous Fpn in HL-60 cells and RF/6A cells and Fpn-GFP in transfected RF/6A cells, with and without Aph infection. We observed distinct localization of Fpn-GFP encircling individual Aph-vacuoles in RF/6A cells after chemical fixation or by live-cell image analysis (Fig. 2A and B). Endogenous Fpn spatial distribution was examined by immunofluorescence (IF) labeling (after chemical fixation and membrane permeabilization) with the 31A5 antibody that can recognize native human Fpn (50). In Aph-infected RF/6A cells (Fig. 2C) and HL-60 cells (Fig. 2D), endogenous Fpn was also found surrounding individual Aph vacuoles. In each case, line scan results spanning Aph-vacuoles showed that Fpn fluorescence (either GFP-tagged or IF-labeled) peaked on both sides of the Hoechst fluorescence (bacterial DNA) peak (Fig. 2A through D). To demonstrate Fpn localization at the Aph-vacuole surface, we examined endogenous Fpn localization with Aph type IV secretion system effector ER-Golgi exit protein of Anaplasma (EgeA), which localizes to the Aph-vacuole surface (38). In Aph-infected HL-60 cells, endogenous Fpn, indeed, colocalized with native EgeA (Fig. 2E; Fig. S2 ). Fpn-GFP was primarily localized on PM in uninfected RF/6A cells, whereas IF labeling of endogenous Fpn in uninfected RF/6A and HL-60 cells showed more homogeneous distribution in the cytoplasm rather than on PM (Fig. 2F). Normal mouse serum control of infected and uninfected cells under the same staining condition did not show non-specific labeling as shown previously (38).
Fig 2.
Fpn-GFP and endogenous Fpn localize to Aph-containing vacuoles. (A) Fpn-GFP (green)-transfected RF/6A cells were infected with host cell-free Aph at 1 dpt. At 3 dpt/2 dpi, cells were fixed and host and bacterial DNA were stained with Hoechst (pseudocolored red). Merge, merge of two fluorescence images. N, nucleus. (B) RF/6A cells were transfected with Fpn-GFP (green) and infected with Aph at 2 dpt. Live cell DNA staining was performed with Hoechst (pseudocolored red), and cells were imaged at 1.5 dpi/3.5 dpt under 37°C and 5% CO2 conditions. (C) Untransfected, Aph-infected RF/6A cells were fixed at 2 dpi, permeabilized, and immunostained with mouse monoclonal anti-human Fpn (31A5, green) and Hoechst. (D) Aph-infected HL-60 cells were fixed at 2 dpi, permeabilized, and stained with anti-Fpn (31A5, green) and Hoechst. (E) Aph-vacuoles of HL-60 cells at 2 dpi, permeabilized, and stained with anti-Fpn (31A5, green), with anti-Aph EgeA (red), and Hoechst (blue). (A–E) boxed area is enlarged 2 × on the right of the respective panel with individual channels and merged image. Relative fluorescence signal intensity plots along the yellow lines in the enlarged merge images show DNA (red line) (A–D), and transfected Fpn-GFP (green line) (A and B) or immunofluorescence-labeled endogenous Fpn (green line) (C–D), showing Fpn peaks encasing bacteria DNA peak in the vacuoles but not overlapping, and (E) EgeA (red line) peaks overlapping with Fpn (green line) on the Aph-vacuole encasing bacterial DNA (blue line) peak. (F) Localization of Fpn-GFP at 2 dpt in uninfected RF/6A cells (Uninf. Ctl), or Fpn (31A5) immunofluorescence in uninfected RF/6A and HL-60 cells (Uninf. Ctl). Scale bars: 10 µm in RF/6A cells; 5 µm in HL-60 cells. Images are representative of three independent experiments.
Fpn-GFP encircling Aph-vacuoles occurs subsequent to bacterial invasion and requires bacterial protein synthesis
Fpn-GFP and endogenous Fpn encircling Aph-vacuoles were evident at exponential to stationary stages of bacterial proliferation (Fig. 2). At this stage, Fpn may appear compressed between crowded Aph-vacuoles (Fig. 2). Next, we examined early time course of Fpn localization when much less Aph is present, and determined when the encircling occurs. First, to determine if Fpn is recruited to the site of bacterial binding to PM, we incubated Aph and Fpn-GFP-transfected RF/6A cells at room temperature. Under this condition, Aph bound to the host cells, but could not internalize, and there were no instances of PM Fpn-GFP colocalization with bound Aph (Fig. 3). At endocytosis-permissive 37°C, Aph began to be internalized (Fig. 3), but Fpn-GFP did not encircle a significant proportion of Aph-vacuoles until 2 h post infection (hpi). Thereafter, increasingly higher proportions of Aph-vacuoles were encircled by Fpn-GFP in a distinct ring-like pattern (Fig. 3). To analyze if encasement of Aph-vacuoles with Fpn-GFP is dependent on active protein synthesis by intracellular Aph, we next assessed effects of bacterial protein synthesis inhibitor tetracycline on Fpn-GFP localization starting at 2 days post infection (dpi). Starting at 2 h of treatment, significant reduction of Aph vacuoles occurred (Fig. 4A and B). Concurrently, Fpn-GFP encasement of the Aph-vacuoles was diminished or lost with tetracycline treatment (Fig. 4A) in a treatment time-dependent manner (Fig. 4C). Additionally, there were punctate patterns of Fpn-GFP observed near or on Aph-vacuoles, suggestive of endosomal/lysosomal Fpn vesicles or vestiges thereof (17, 51). The abundance of these puncta on individual Aph-vacuoles was not significantly different during 2–24 h tetracycline treatment (Fig. 4D). Taken together, these results indicate that both active intracellular bacteria and infection-induced host cell signaling must occur to induce Fpn encasement of Aph vacuoles.
Fig 3.
Fpn-GFP localization to Aph vacuoles occurs subsequent to bacterial entry. (A) Host cell-free Aph was added to Fpn-GFP-transfected RF/6A cells at 2 dpt at room temperature (RT) to allow only binding, or at 37°C to allow binding and internalization, and harvested at indicated hpi. Aph DNA was labeled with Hoechst (pseudocolored red) and Aph was labeled with anti-Aph (pseudocolored white). Merge, merge of Hoechst and Fpn-GFP images (bar, 10 µm). Each boxed area is enlarged 5 × on the right (bar, 5 µm). (B) Relative fluorescence signal intensity profiles between Fpn-GFP (green), and Aph DNA (red) along the yellow line in enlarged merged image in A, show the Fpn peaks are encasing bacteria DNA peak within the vacuoles starting at 2 hpi. (C) Percentage of vacuoles encased with Fpn-GFP per cell. >800 vacuoles or bacteria were counted across at least 20 cells at each time point. One-way ANOVA ****P < 0.0001, **P < 0.01, ns, not significant. Images are representative of three independent experiments.
Fig 4.
Fpn-GFP localization to Aph-vacuoles is dependent on Aph protein production. (A) RF6/A cells were transfected with Fpn-GFP, infected with host cell-free Aph (MOI: 250), and treated with 5 µg/mL tetracycline for the indicated periods immediately proceeding harvest at 3 dpt/2 dpi. Host and Aph DNA, labeled with Hoechst (pseudocolored red), and Fpn-GFP (green) fluorescence were imaged. Merge, merge of Hoechst and Fpn-GFP images (bar, 10 µm). Each boxed area is enlarged 3 × on the right (bar, 5 µm). (B) % of Aph infection determined by area of Aph (µm2)/area of Fpn-GFP expressing host cell (µm2) *100. N = 10–16 cells per treatment period. (C) % of Aph vacuoles with circling, non-fragmented Fpn-GFP rings scored in ImageJ. >150 Aph-vacuoles were counted from 10 cells per treatment period. (D) Number of Fpn-GFP puncta on individual Aph-vacuoles. ≥60 Aph-vacuoles were counted from 10 cells per treatment period. One-way ANOVA, ns, not significant; *P < 0.05, **P < 0.01, ****P < 0.0001. Data representative of two independent experiments.
Fpn ubiquitination motifs are necessary for Fpn-GFP localization to Aph-vacuoles
To investigate if PM Fpn internalization is required for Fpn localization to Aph-vacuoles, we used Fpn mutants: Fpn (∆229–269)-GFP, Fpn (∆225–247)-GFP, and Fpn (∆247–269)-GFP, which lack the intracellular domain between positions 225–290 (Fig. S3) and are expressed on PM, but cannot internalize in response to Hepc (20). Each of these mutant plasmids had similar transfection efficiencies and expression levels (Fig. S4), yet, our results showed Fpn mutants significantly less frequently encircled Aph-vacuoles than WT (wild-type) Fpn (Fig. 5). The lysine residues in Fpn residue 225–290 (Fig. S3) are the sites for ubiquitination and are required for Hepc-induced internalization (18). Thus, we used Fpn(K8R)-GFP (18) to test if these lysine are required for Fpn localization to Aph-vacuoles, which showed significant less Fpn(K8R) mutant encircling of Aph-vacuoles (Fig. 5). Lastly, Fpn(Y64H) is a natural point mutation in humans that binds Hepc (18, 52). Fpn(Y64H)-GFP can export iron, but upon Hepc treatment, it is not ubiquitinated nor internalized (19, 53). Fpn (Y64H)-GFP encircled Aph-vacuoles significantly less than WT Fpn (Fig. 6). These results altogether suggest that Hepc-induced Fpn internalization pathway is required for Fpn localization to Aph-vacuoles.
Fig 5.
Fpn-GFP motifs for ubiquitination are required for Fpn-GFP localization to Aph-vacuoles. All lysine residues of Fpn-GFP (K8R) between positions 225–269 are substituted for arginine. This mutant along with ∆229–269, ∆225–247, and ∆247–269 are deficient in Hepc-induced ubiquitination. (A) Aph was added to Fpn (WT or indicated mutant)-GFP (green)-transfected RF/6A cells at 2 dpt, and cells were harvested at 8 hpi. Aph DNAs were labeled with Hoechst (pseudocolored red). Merge, merge of Hoechst and Fpn-GFP images (bar, 10 µm). Each boxed area is enlarged 3.5 × on the right (bar, 5 µm). Relative fluorescence signal intensity profiles between Fpn-GFP (green), and Aph DNA (red) along the yellow line in enlarged merged image, showing the Fpn peaks and bacteria DNA peak. (B) Percentage of Aph-vacuoles encased with Fpn-GFP. >200 vacuoles were scored in at least in 12 cells per condition. One-way ANOVA, ****P < 0.0001. Data are representative of three independent experiments.
Fig 6.
Fpn-GFP (Y64H), which binds Hepc but cannot internalize, does not localize to Aph-vacuoles. (A) Aph was added to Fpn (WT or Y64H)-GFP (green)-transfected RF/6A cells at 2 dpt, and cells were harvested at 12 hpi. Aph and host DNAs were labeled with Hoechst (pseudocolored red). N, Nucleus. Merge, merge of Hoechst and Fpn-GFP images (bar, 10 µm). Boxed areas are enlarged 3 × on the right (bar, 5 µm). (B) Percentage of Aph-containing vacuoles with encircled Fpn-GFP was scored by Image J. > 400 Aph-vacuoles were counted from 15 cells per condition. Student’s t-test, ****P < 0.0001. Data representative of two independent experiments.
Iron binding/transport deficient mutants do not increase LIP in Aph-vacuoles or Aph replication
Fpn’s iron export and Hepc-binding abilities are closely linked, but residues that are most important for iron binding/export and independent from Hepc binding are D39 and D181 (Fig. S3 and S5) (54–56). We, thus, tested if Fpn (D39A)-GFP or Fpn (D181V)-GFP can encircle Aph-vacuoles, and increase vacuolar LIP, and/or promote Aph growth vs Fpn (WT)-GFP. The results showed both Fpn (D39A)-GFP and Fpn (D181V)-GFP can encircle Aph-vacuoles, like Fpn (WT)-GFP (Fig. 7B through D). Fpn (WT)-GFP enhanced relative LIP levels in Aph-vacuoles/host cell cytoplasm compared to Aph-vacuoles of un-transfected cells, but not in Fpn (D39A)- or Fpn (D181V)-transfected cells (Fig. 7B through E). In turn, Aph growth within WT-expressing cells was greater than in un-transfected cells, or Fpn (D39A)- or Fpn (D181V)-transfected cells (Fig. 7F and G), suggesting that not only encircling Aph-vacuoles, but also the ability of Fpn to transport iron is required to enrich intravacuolar LIP and enhance Aph growth.
Fig 7.
Iron binding/transport deficient mutants do not increase LIP in Aph-vacuoles or Aph replication RF/6A cells were transfected with plasmids encoding WT, D39A, or D181V Fpn-GFP (colored green) and infected with host cell-free Aph. At 1.5 dpi and 3.5 dpt, cells were dyed with FerroFarRed to detect LIP (colored red) and Hoechst 33342 dye (pseudo-colored cyan) for the detection of host and Aph DNAs. Live cells were imaged under a Leica DMi8 Thunder microscope at 37°C. (A) Un-transfected (UT), (B) Transfected with Fpn-GFP (WT), (C) Transfected with Fpn-GFP (D39A), or (D) Transfected with Fpn-GFP (D181V). Merge, merge of LIP, Hoechst, and indicated Fpn-GFP mutant (bar, 10 µm). Yellow-boxed areas are enlarged 2.5 × on the right (bar, 5 µm). Aph-vacuole boundaries determined in ImageJ by globular, non-nuclear Hoechst fluorescence. (E) Iron content measured by LIP MFI of vacuoles normalized by the Aph area % of the infected cell. N = 541–1,324 vacuoles. (F) % of Aph area/cell determined by area (µm2) of Aph-vacuoles/area (µm2) of GFP-expressing cell * 100. N = 30–45 cells. (G) Total Aph-vacuole numbers were enumerated in GFP-expressing cells for each plasmid type. N = 30–45 cells. Statistics: One-Way ANOVA to WT control, ***P < 0.001, ****P < 0.0001. Data representative of three independent experiments.
Aph infection induces production of autologous HAMP mRNA and elevates Hepc protein levels
As Fpn domains required for localization to Aph vacuoles were those required for Fpn internalization in response to Hepc, which is encoded by HAMP, we examined if Aph infection induces HAMP expression. The RT-qPCR detected amplification of a low abundance of endogenous HAMP mRNA, which was elevated by Aph infection of RF/6A cells (Fig. 8A). As the primary cell type infected by Aph is granulocytes, we next examined HAMP mRNA in HL-60 cells. Here, HAMP mRNA was dramatically upregulated by Aph infection (Fig. 8B). Since HAMP translation produces prohepcidin which is processed to small active Hepc (57), we evaluated Hepc protein levels in uninfected or Aph-infected HL-60 cells. Western blot analysis using anti-human Hepc showed that Aph infection increases prohepcidin protein in HL-60 cells (similar size as in references 58, 59) (Fig. 8C and D). The HAMP gene is strongly upregulated in human hepatoma cells by the proinflammatory cytokine IL-6 (60); thus, we examined if Aph infection induces proinflammatory cytokines. Results showed IL-6, IL-1ß, and TNF⍺ mRNA were significantly upregulated after infection of HL-60 cells, with dramatic increase in IL-6 (Fig. 8E). These results altogether strongly indicate that Aph-induced inflammation subverts the Hepc/Fpn axis to encircle Aph-vacuoles with Fpn, which might export iron into vacuoles for Aph growth (Fig. 9).
Fig 8.
Aph infection induces production of Hepc by the host cells. (A and B) Relative HAMP mRNA levels normalized to human HPRT mRNA (∆∆Ct) in uninfected and Aph-infected (A) RF/6A cells at 48 hpi, or (B) HL-60 cells at 12 hpi. (C) Lysates from uninfected and Aph-infected HL-60 cells at 2 dpi were analyzed by western blotting using antibodies against human Hepc, human actin, and Aph P44. (D) The relative band density of Hepc was normalized against actin with the level of the uninfected group set as 1. (E) Relative mRNA abundance of human TNF⍺, IL-6, and IL-1β from samples normalized to human HPRT in HL-60 cells as in (B) by the ∆∆Ct method. Data represent the mean ± SD from three independent experiments. Student’s t-test, *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
Fig 9.

Hypothetical model: Infection-induced Hepc internalizes Fpn to Aph vacuole localization which facilitates iron uptake by Aph. PM Fpn exports iron from the cell. After Aph invasion, proinflammatory cytokines are upregulated concurrently with Hepc that induces endocytosis of Fpn, allowing Fpn endosomes to target Aph-vacuoles. Fpn localization on Aph-vesicles is vectorially positioned to transport Fe2+ from cytosolic sources into Aph-vacuole lumen, promoting bacterial growth. PM: plasma membrane, Fe2+: ferrous molecules, Aph: Anaplasma phagocytophilum, Fpn: ferroportin.
DISCUSSION
Fpn regulation is an important innate nutritional iron immune mechanism against intracellular infection. Increased expression of Fpn limits Chlamydia psittaci, C. trachomatis, or Legionella pneumophila infection (10). Fpn in the PM is co-internalized with Staphylococcus aureus, Salmonella typhimurium, or IgG-coated beads when phagocytosed by macrophages, but then rapidly (<15 min) removed from phagosomes and recycled back to the PM (61). In Salmonella infection of HeLa cells, some iron transport-competent Fpn remains on the Salmonella-containing vacuoles, functioning as a killing mechanism (28). Thus, these known Fpn-targeting host innate immune mechanisms against intracellular pathogens are (i) maintaining or increasing PM Fpn levels to reduce total intracellular Fe2+, (ii) removing Fpn from pathogen-containing phagosomes to prevent nutritional iron uptake, and/or (iii) selectively targeting Fpn to pathogen-containing phagosomes to inhibit infection by iron overload toxicity. In contrast, our current study revealed Aph subverts this nutritional immunity by recruiting Fpn to its replicative vacuole to promote its proliferation.
Subcellular localization of Fpn is variable. Most commonly, in HEK293 cells, Xenopus oocytes, MDCK cells, and hepatocytes, tagged-Fpn and endogenous Fpn are generally dispersed on the plasma membrane for export (17, 24, 51, 62). However, in duodenum enterocytes, Fpn localization is polarized to the basolateral side to release iron into circulation (23, 24, 62). Additionally, there are numerous reports of intracellular Fpn, such as in Kupffer cells, HEK293T cells, HK2 cells, and primary macrophages and macrophage cell lines, which implicate Fpn association with endosomal, lysosomal, and ER membranes (17, 24, 51, 63, 64). Fpn antibodies, membrane-permeabilization required for antibody staining, and Fpn-GFP transfection methods may also contribute to some of this variance. In this study, Fpn-GFP appeared on the PM of RF/6A epithelial cells and dispersed bright intracellular puncta. The 31A5 antibody (50), which recognizes a 5-residue epitope of the extracellular loop, stained both the RF/6A cells and HL-60 cells predominantly intracellularly. Additionally, while HAMP mRNA was detected in both cell types, it was upregulated by Aph infection ~10-fold greater in HL-60 than RF/6A cells. It is possible that HL-60 cells have a predisposition for intracellular vesicular Fpn which permits these cells to be readily infected by Aph. Indeed, HL-60 cell is the only mammalian cell line used successfully to culture isolate Aph from HGA patients’ blood (2, 49). In at least mouse macrophages, Fpn has been reported to be associated to lipid rafts, which is crucial for Fpn internalization (65). Notably, the Aph-vacuole is also enriched with proteins in lipid rafts in HL-60 and THP-1 cells (66, 67). Investigation of PM and intracellular Fpn trafficking across various cell types during infection will help further understanding Aph subversion of Fpn-mediated iron homeostasis and Fpn cell biology itself.
FerroFarRed is membrane-permeable and localizes in the endoplasmic reticulum (ER), making it to be advantageous for specific intracellular studies (44, 45). Both Fpn and LIP had granular appearance, suggesting they are in membrane-bound vesicles. When Fpn is endocytosed, vectorial orientation of iron transport is from cytoplasm to endosome lumen (Fig. 9). Thus, if Fpn endosomes fuse with Aph-vacuoles, iron is imported into the lumen of Aph-vacuoles (Fig. 9). Indeed, WT Fpn-GFP increased LIP in Aph vacuoles. We recently reported Aph recruits ER-Golgi exit sites to pathogen-occupied vacuoles using Aph-secreted protein, EgeA (38). Thus, a vesicular nature of FerroFarRed localized around Aph vacuoles may be retrograde-transported endosomes containing Fpn and ER-Golgi LIP.
Hepc decreases PM Fpn expression, consequently enhancing some intracellular pathogen infections. In macrophages infected with Chlamydia psittaci, C. trachomatis, or Legionella pneumophila, the addition of Hepc enhances their intracellular growth (10). On the other hand, protozoan Leishmania donovanii decreases Fpn protein levels in spite of upregulated mRNA and no induction of Hepc. Instead, L. donovanii represses de novo Fpn translation via FBXL5/Iron Regulatory Protein-2 (IRP) interactions with the Iron Responsive Element of Fpn mRNA (27). Some bacterial pathogens induce Hepc in macrophages and neutrophils in vitro and in vivo in a toll-like receptor 4 (TLR4)-dependent manner (22). However, undifferentiated HL-60 cells express low levels of TLR4 (68), and a defining trait of Aph is the absence of lipopolysaccharide (69), the ligand for TLR4. The LPS-TLR4 axis is, therefore, unlikely to directly drive Hepc production in Aph-infected HL-60 cells. Recently, it was reported that TLR5 or TLR2:TLR6 heterodimer activation in murine primary hepatocytes induces HAMP mRNA (70). Again, as Aph also lacks TLR5 ligand, flagella, or TLR6 ligand, diacyl peptides (36), and expression of TLR2 in undifferentiated HL-60 cells is low (68), these pathways may not be involved in HAMP mRNA upregulation in Aph infection.
Systemic HAMP gene transcriptional regulation involves signaling of iron levels and inflammation, both transcriptionally and post-transcriptionally. HAMP transcriptional activation requires the BMP/SMAD and HNF4α pathways and IL-6 activation of STAT3 (71–73) and stabilization of HAMP mRNA occurs through the HuR protein (74), but it is uncertain if these pathways are also involved locally in any infected cells. Likewise, pathogen-associated molecular patterns induce inflammation via TLR2/6 for downstream NF-κB crosstalk with Nrf2 to influence histone activity at the Fpn promoter, decreasing Fpn transcription which may increase the LIP available to pathogens (29). Clearly, though regulation of Hepc and Fpn can be advantageous for pathogens, there is no single universal model by which pathogens may accomplish this feat. Thus, more understanding of diverse mechanisms will be the key for developing Aph-specific or broadly effective therapeutics.
In vitro stimulation of fresh human hepatocytes with a panel of cytokines showed strong induction of Hepc mRNA by IL-6, but not IL-1α or TNF-α (75), indicating that IL-6 is a primary proinflammatory mediator of Hepc induction at a local level (60). Within 2 h after addition of Aph, IL-6, IL-1ß, and TNF-α mRNAs are induced in human peripheral blood leukocytes (PBLs) in vitro (76). In the present study, Aph-infection of HL-60 cells closely matched cytokine expression of infected human PBLs. Thus, Hepc upregulation in HL-60 cells by Aph infection may be a consequence of infection-induced inflammation and co-opted by Aph for Fpn internalization. Relatedly, ferritin acts as an acute-phase reactant, with levels rising sharply due to inflammation, infection, or cell damage, not only by iron overload (73, 77). The present study revealed Aph is able to upregulate cellular ferritin light chain protein in HL-60 cells in the landscape of IL-6 upregulation; thus, infection-induced inflammation may have multifaceted roles in iron availability to Aph. In contrast, a previous study reported diminished ferritin complex level in HL-60 cells after Aph infection, despite an increase in ferritin mRNA (primarily heavy chain), but also increases in ferritin complex and light chain mRNA in infected neutrophils (78). Reasons for these discrepancies are unclear. Interestingly, iron sensing by IRP-1 activity in human monocytic leukemia cell line THP-1 is unchanged by Aph infection (32), suggesting impaired intracellular iron sensing and regulation of iron metabolism by IRP-1 may also be an important contributing factor in Aph infection.
Both Fpn-GFP and endogenous Fpn infection did not drive all of the cellular Fpn to the Aph-vacuole. Thus, there is fine tuning and regulation for subversion of the inflammation-Hepc-Fpn axis that balances Fpn degradation, leaving a part of Fpn routed to—and sufficient for—the Aph-vacuole. Ultimately, this serves two purposes: to increase the stockpile of iron within the cell and to provide a means of transferring it across the Aph-vacuolar membrane. As Fpn does not co-localize or co-endocytose with extracellular Aph and Aph protein production is required to maintain colocalization, a distinct signal for Fpn internalization and targeting to Aph vacuoles is generated by viable intravacuolar bacteria.
MATERIALS AND METHODS
Aph and cell culture
Cultivation of Aph (HZ) in HL-60 cells (ATCC, Manassas, VA), preparation of host cell-free Aph via Dounce Homogenization, and infection were performed as described (49, 79). RF/6A monkey endothelial cells (ATCC) were cultured as described (43, 80). For experiments involving tetracycline, 5 µg/mL tetracycline (Sigma, St Lois, IL) was added to cultures at indicated timepoints.
Plasmids
Plasmids encoding Fpn-GFP (WT) and Fpn-GFP mutants K8R, ∆229–269, ∆225–247, and ∆247–269 were previously described (20). For plasmids constructed in this study, primer sequences, and cloning strategies are described in Tables S1 and S2. Fpn-GFP mutants Y64H, D39A, and D181V were generated from Fpn-GFP (WT) using Q5 Site Directed Mutagenesis Kit (New England Biolabs, Ipswich, MA). Plasmids were purified with E.Z.N.A. Endo-free Plasmid DNA Mini Kit I (Omega Bio-tek, Norcross, GA), Endo-Free Maxi Kit (Qiagen, Hilden, Germany), or Nucleobond Midi EF Kit (Machery-Nagel, Düren, Germany).
Antibodies
The mouse monoclonal antibody (mAb) 5C11 specific to Aph P44 and anti-EgeA were described previously (38, 47). Horse antiserum immunoreactive with Aph (anti-Aph) from was preadsorbed with uninfected cell culture before use. The mouse anti-human Fpn (31A5) antibody was provided by Amgen, Inc. (Thousand Oaks, CA). The following antibodies were obtained from commercial sources—Santa Cruz Biotechnology (Dallas, TX): mouse anti-human β-actin (C4); Novus Biologicals (Centennial, CO): rabbit anti-human Fpn (21502); Alpha Diagnostics International (San Antonio, TX): rabbit anti-human Hepc (HEPC13-S). Secondary antibodies including Alexa Fluor 488 (AF488)-conjugated goat anti-mouse IgG and AF555-conjugated goat anti-rabbit IgG were obtained from Thermo Fisher, Cy3-conjugated goat anti-horse Ig was obtained from Jackson Immunoresearch, and peroxidase-labeled goat anti-mouse or anti-rabbit secondary antibodies were obtained from Seracare (Milford, MA).
RT-qPCR
At indicated times post infection, cells were washed with phosphate-buffered saline (PBS; 8 mM Na2HPO4, 1.47 mM KH2PO4, 2.67 mM KCl, 137.9 mM NaCl, pH 7.4), and RNAs were extracted with the RNeasy Mini kit (Qiagen, Germantown, MD). cDNA was synthesized using the Maxima H minus First Strand cDNA Synthesis kit with Random Hexamer primers (Thermo Fisher Scientific, Waltham, MA), and bacterial and host gene expressions were determined by RT-qPCR with specific primers for Aph 16S rRNA (81), human genes HPRT (this study), HAMP (82), TNF⍺ (83), IL-1ß (84), and IL-6 (85) (Table S2), using Maxima SYBR Green/ROX Master Mix (Thermo Fisher Scientific) in an AriaMx Real-time PCR system (Agilent, Santa Clara, CA) according to the manufacturers’ instructions.
Western blot analysis
Uninfected or Aph-infected cells at 2 dpi were washed with PBS, and soluble protein was extracted using commercial mammalian protein extraction reagent (M-PER, ThermoFisher Scientific). Following high speed centrifugation, soluble protein was reduced with 5 × loading buffer (30% Glycerol, 2.3 M 2-mercaptoethanol, 4% [wt/vol] SDS, 0.03% bromophenol blue, 250 mM Tris-HCl pH 6.8) and denatured by boiling for 5 min. Proteins were separated by 10% (Actin and P44), 12% (FTL), or 15% (Hepc) SDS-PAGE gel electrophoresis followed by semi-dry transfer to 0.45 µm nitrocellulose (actin, P44, and Hepc) or methanol-activated 0.2 µm PVDF (FTL). Protein loads were normalized by BCA Assay (Pierce, Rockford, IL) and verified by Ponceau S staining of the membrane and anti-actin immunoblots. Membranes were blocked and blotted with 5% skim milk and 0.05% Tween-20 in Tris-buffered saline (TBS, 15 mM NaCl and 5 mM Tris, pH 7.4) and developed with ECL Detection Reagent (ThermoFisher Scientific). Chemiluminescence was photographed with a GE Amersham Imager 680 (GE Healthcare, Chicago, IL) and band densities recorded in NIH ImageJ.
Transfection, IF labeling, and cellular localization analysis
RF/6A cells adhered to coverslips were transfected using FuGENE HD reagent (Promega, Madison, WI) with plasmids at 3:1 ratio (3 μL FuGENE HD:1 μg plasmids) in a 12-well plate according to the manufacturer’s instructions. Cells were then infected with host cell free Aph at MOI 500 at timepoints indicated. In some experiments, cells were infected by co-culture with highly infected HL-60 cells for 1 day prior to transfection. For IF labeling, cells were fixed and permeabilized with ice cold 80% methanol/20% acetone and labeled with primary then fluorescently conjugated secondary antibodies diluted in 0.05% bovine serum albumin (BSA, Sigma-Aldrich). In some experiments, cells were fixed with 4% paraformaldehyde (Sigma) and labeled with primary and then fluorescence-conjugated secondary antibodies diluted in PBS supplemented with 0.1% gelatin (Bio-Rad, Hercules, CA), 0.05% BSA, and 0.1% saponin (Sigma) (PGBS). Uninfected HL-60 cells or Aph-infected HL-60 cells were cytocentrifuged onto a microscope slide, fixed with 4% paraformaldehyde, and permeabilized with PGBS. Double immuno-labeling was carried out by successive staining in PGBS with anti-Fpn 31A5 primary and secondary anti-mouse IgG antibodies, then primary anti-Aph EgeA and secondary anti-rabbit IgG antibodies. In all experiments, the host cell nuclei and A. phagocytophilum DNA were labeled with Hoechst 33342 (Thermo Fisher Scientific).
LIP analysis
For live cell LIP analysis, RF/6A cells were adhered onto glass-bottom tissue culture dishes (CellVis, Mountain View, CA) and infected with host cell-free Aph for 2 days. LIP was detected after incubation with 5 µM FerroFarRed dye (Sigma-Aldrich) for 1 h at 37°C with 5% CO2 using an Oko-Labs (Pozzuoli, NA, Italy) incubation chamber microscope mount. Nuclei and Aph were labeled with Hoechst, and then live cells were observed under Leica Thunder Imager at 37°C (35). For LIP analysis of Aph occupying Fpn(WT)-GFP, Fpn(D39A)-GFP, and Fpn(D181V)-GFP-transfected RF/6A cells were infected with host cell-free Aph (MOI: 500) at 2 dpt (day post transfection). At 1.5 dpi (3.5 dpt), cells were incubated with 5 μM FerroFarRed at 37°C for 1 h.
Image analysis
Fluorescence images with overlaid differential interference contrast (DIC) images were acquired under the same settings among experimental groups and analyzed with a Leica Thunder imaging system with computational clearing to remove any out-of-focus background (Leica Microsystems, Deerfield, IL). NIH ImageJ software was used to measure line scan relative signal intensities or area mean fluorescent intensities. A macro (described in Fig. S1) was written to randomly locate and calculate the area of a defined ROI dimensions of each Aph-vacuole to measure FerroFarRed mean fluorescence intensity (MFI) of “non-vacuoles” from infected or uninfected cells within the same field of view.
Statistical analysis
Statistical analysis was performed with Student’s unpaired t test or a one-way analysis of variance (ANOVA). P < 0.05 was considered statistically significant. All statistical analyses were performed using Prism 10 (GraphPad, La Jolla, CA).
ACKNOWLEDGMENTS
This study was funded, in part, by a R01AI151065 grant to Y.R. from the National Institutes of Health.
Footnotes
This article is a direct contribution from Yasuko Rikihisa, a Fellow of the American Academy of Microbiology, who arranged for and secured reviews by Francois Canonne-Hergaux, INSERM, and Sergei Nekhai, Howard University.
Contributor Information
Yasuko Rikihisa, Email: rikihisa.1@osu.edu.
Michael T. Laub, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
DATA AVAILABILITY
Data will be made publicly available upon publication and upon request for peer review.
SUPPLEMENTAL MATERIAL
The following material is available online at https://doi.org/10.1128/mbio.01134-26.
Fig. S1-S5; Tables S1 and S2.
ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse.
REFERENCES
- 1. Biggs HM, Behravesh CB, Bradley KK, Dahlgren FS, Drexler NA, Dumler JS, Folk SM, Kato CY, Lash RR, Levin ML, Massung RF, Nadelman RB, Nicholson WL, Paddock CD, Pritt BS, Traeger MS. 2016. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis - United States. MMWR Recomm Rep 65:1–44. doi: 10.15585/mmwr.rr6502a1 [DOI] [PubMed] [Google Scholar]
- 2. Goodman JL, Nelson C, Vitale B, Madigan JE, Dumler JS, Kurtti TJ, Munderloh UG. 1996. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med 334:209–215. doi: 10.1056/NEJM199601253340401 [DOI] [PubMed] [Google Scholar]
- 3. Sanchez E, Vannier E, Wormser GP, Hu LT. 2016. Diagnosis, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: a review. JAMA 315:1767–1777. doi: 10.1001/jama.2016.2884 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Gygax L, Schudel S, Kositz C, Kuenzli E, Neumayr A. 2024. Human monocytotropic ehrlichiosis-A systematic review and analysis of the literature. PLoS Negl Trop Dis 18:e0012377. doi: 10.1371/journal.pntd.0012377 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Chen SM, Dumler JS, Bakken JS, Walker DH. 1994. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol 32:589–595. doi: 10.1128/jcm.32.3.589-595.1994 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Maeda K, Markowitz N, Hawley RC, Ristic M, Cox D, McDade JE. 1987. Human infection with Ehrlichia canis, a leukocytic rickettsia. N Engl J Med 316:853–856. doi: 10.1056/NEJM198704023161406 [DOI] [PubMed] [Google Scholar]
- 7. Dawson JE, Anderson BE, Fishbein DB, Sanchez JL, Goldsmith CS, Wilson KH, Duntley CW. 1991. Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis. J Clin Microbiol 29:2741–2745. doi: 10.1128/jcm.29.12.2741-2745.1991 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Cassat JE, Skaar EP. 2013. Iron in infection and immunity. Cell Host Microbe 13:509–519. doi: 10.1016/j.chom.2013.04.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Wandersman C, Delepelaire P. 2004. Bacterial iron sources: from siderophores to hemophores. Annu Rev Microbiol 58:611–647. doi: 10.1146/annurev.micro.58.030603.123811 [DOI] [PubMed] [Google Scholar]
- 10. Paradkar PN, De Domenico I, Durchfort N, Zohn I, Kaplan J, Ward DM. 2008. Iron depletion limits intracellular bacterial growth in macrophages. Blood 112:866–874. doi: 10.1182/blood-2007-12-126854 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Skaar EP. 2010. The battle for iron between bacterial pathogens and their vertebrate hosts. PLoS Pathog 6:e1000949. doi: 10.1371/journal.ppat.1000949 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Jabado N, Cuellar-Mata P, Grinstein S, Gros P. 2003. Iron chelators modulate the fusogenic properties of Salmonella-containing phagosomes. Proc Natl Acad Sci USA 100:6127–6132. doi: 10.1073/pnas.0937287100 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Jabado N, Jankowski A, Dougaparsad S, Picard V, Grinstein S, Gros P. 2000. Natural resistance to intracellular infections: natural resistance-associated macrophage protein 1 (Nramp1) functions as a pH-dependent manganese transporter at the phagosomal membrane. J Exp Med 192:1237–1248. doi: 10.1084/jem.192.9.1237 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Forbes J, Lam-Yuk-Tseung S, Gros P. 2006. Modulation of iron availability at the host-pathogen interface in phagocytic cells. EcoSal Plus 2. doi: 10.1128/ecosalplus.8.8.10 [DOI] [PubMed] [Google Scholar]
- 15. Drakesmith H, Prentice AM. 2012. Hepcidin and the iron-infection axis. Science 338:768–772. doi: 10.1126/science.1224577 [DOI] [PubMed] [Google Scholar]
- 16. Armitage AE, Eddowes LA, Gileadi U, Cole S, Spottiswoode N, Selvakumar TA, Ho L-P, Townsend ARM, Drakesmith H. 2011. Hepcidin regulation by innate immune and infectious stimuli. Blood 118:4129–4139. doi: 10.1182/blood-2011-04-351957 [DOI] [PubMed] [Google Scholar]
- 17. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J. 2004. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090–2093. doi: 10.1126/science.1104742 [DOI] [PubMed] [Google Scholar]
- 18. Aschemeyer S, Qiao B, Stefanova D, Valore EV, Sek AC, Ruwe TA, Vieth KR, Jung G, Casu C, Rivella S, Jormakka M, Mackenzie B, Ganz T, Nemeth E. 2018. Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin. Blood 131:899–910. doi: 10.1182/blood-2017-05-786590 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Fernandes A, Preza GC, Phung Y, De Domenico I, Kaplan J, Ganz T, Nemeth E. 2009. The molecular basis of hepcidin-resistant hereditary hemochromatosis. Blood 114:437–443. doi: 10.1182/blood-2008-03-146134 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Qiao B, Sugianto P, Fung E, Del-Castillo-Rueda A, Moran-Jimenez MJ, Ganz T, Nemeth E. 2012. Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination. Cell Metab 15:918–924. doi: 10.1016/j.cmet.2012.03.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Michels K, Nemeth E, Ganz T, Mehrad B. 2015. Hepcidin and host defense against infectious diseases. PLoS Pathog 11:e1004998. doi: 10.1371/journal.ppat.1004998 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Peyssonnaux C, Zinkernagel AS, Datta V, Lauth X, Johnson RS, Nizet V. 2006. TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood 107:3727–3732. doi: 10.1182/blood-2005-06-2259 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A, Barut B, Zapata A, Law TC, Brugnara C, Lux SE, Pinkus GS, Pinkus JL, Kingsley PD, Palis J, Fleming MD, Andrews NC, Zon LI. 2000. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403:776–781. doi: 10.1038/35001596 [DOI] [PubMed] [Google Scholar]
- 24. Abboud S, Haile DJ. 2000. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275:19906–19912. doi: 10.1074/jbc.M000713200 [DOI] [PubMed] [Google Scholar]
- 25. Grander M, Hoffmann A, Seifert M, Demetz E, Grubwieser P, Pfeifhofer-Obermair C, Haschka D, Weiss G. 2022. DMT1 protects macrophages from Salmonella infection by controlling cellular iron turnover and lipocalin 2 expression. Int J Mol Sci 23:6789. doi: 10.3390/ijms23126789 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Willemetz A, Beatty S, Richer E, Rubio A, Auriac A, Milkereit RJ, Thibaudeau O, Vaulont S, Malo D, Canonne-Hergaux F. 2017. Iron- and hepcidin-independent downregulation of the iron exporter ferroportin in macrophages during Salmonella infection. Front Immunol 8:498. doi: 10.3389/fimmu.2017.00498 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Das NK, Sandhya S, G. VV, Kumar R, Singh AK, Bal SK, Kumari S, Mukhopadhyay CK. 2018. Leishmania donovani inhibits ferroportin translation by modulating FBXL5-IRP2 axis for its growth within host macrophages. Cell Microbiol 20:e12834. doi: 10.1111/cmi.12834 [DOI] [PubMed] [Google Scholar]
- 28. Lim D, Kim KS, Jeong JH, Marques O, Kim HJ, Song M, Lee TH, Kim JI, Choi HS, Min JJ, Bumann D, Muckenthaler MU, Choy HE. 2018. The hepcidin-ferroportin axis controls the iron content of Salmonella-containing vacuoles in macrophages. Nat Commun 9:2091. doi: 10.1038/s41467-018-04446-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Marques O, Horvat NK, Zechner L, Colucci S, Sparla R, Zimmermann S, Neufeldt CJ, Altamura S, Qiu R, Müdder K, Weiss G, Hentze MW, Muckenthaler MU. 2025. Inflammation-driven NF-κB signaling represses ferroportin transcription in macrophages via HDAC1 and HDAC3. Blood 145:866–880. doi: 10.1182/blood.2023023417 [DOI] [PubMed] [Google Scholar]
- 30. Mott J, Barnewall RE, Rikihisa Y. 1999. Human granulocytic ehrlichiosis agent and Ehrlichia chaffeensis reside in different cytoplasmic compartments in HL-60 cells. Infect Immun 67:1368–1378. doi: 10.1128/IAI.67.3.1368-1378.1999 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Rikihisa Y. 2010. Anaplasma phagocytophilum and Ehrlichia chaffeensis: subversive manipulators of host cells. Nat Rev Microbiol 8:328–339. doi: 10.1038/nrmicro2318 [DOI] [PubMed] [Google Scholar]
- 32. Barnewall RE, Ohashi N, Rikihisa Y. 1999. Ehrlichia chaffeensis and E. sennetsu, but not the human granulocytic ehrlichiosis agent, colocalize with transferrin receptor and up-regulate transferrin receptor mRNA by activating iron-responsive protein 1. Infect Immun 67:2258–2265. doi: 10.1128/IAI.67.5.2258-2265.1999 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Barnewall RE, Rikihisa Y. 1994. Abrogation of gamma interferon-induced inhibition of Ehrlichia chaffeensis infection in human monocytes with iron-transferrin. Infect Immun 62:4804–4810. doi: 10.1128/iai.62.11.4804-4810.1994 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Barnewall RE, Rikihisa Y, Lee EH. 1997. Ehrlichia chaffeensis inclusions are early endosomes which selectively accumulate transferrin receptor. Infect Immun 65:1455–1461. doi: 10.1128/iai.65.4.1455-1461.1997 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Yan Q, Zhang W, Lin M, Teymournejad O, Budachetri K, Lakritz J, Rikihisa Y. 2021. Iron robbery by intracellular pathogen via bacterial effector-induced ferritinophagy. Proc Natl Acad Sci USA 118:e2026598118. doi: 10.1073/pnas.2026598118 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Dunning Hotopp JC, Lin M, Madupu R, Crabtree J, Angiuoli SV, Eisen JA, Seshadri R, Ren Q, Wu M, Utterback TR, et al. 2006. Comparative genomics of emerging human ehrlichiosis agents. PLoS Genet 2:e21. doi: 10.1371/journal.pgen.0020021 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Niu H, Yamaguchi M, Rikihisa Y. 2008. Subversion of cellular autophagy by Anaplasma phagocytophilum. Cell Microbiol 10:593–605. doi: 10.1111/j.1462-5822.2007.01068.x [DOI] [PubMed] [Google Scholar]
- 38. Wang L, Lin M, Hou L, Rikihisa Y. 2024. Anaplasma phagocytophilum effector EgeA facilitates infection by hijacking TANGO1 and SCFD1 from ER–Golgi exit sites to pathogen-occupied inclusions. Proc Natl Acad Sci USA 121:e2405209121. doi: 10.1073/pnas.2405209121 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Rikihisa Y. 2011. Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum. Clin Microbiol Rev 24:469–489. doi: 10.1128/CMR.00064-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Munderloh UG, Lynch MJ, Herron MJ, Palmer AT, Kurtti TJ, Nelson RD, Goodman JL. 2004. Infection of endothelial cells with Anaplasma marginale and A. phagocytophilum. Vet Microbiol 101:53–64. doi: 10.1016/j.vetmic.2004.02.011 [DOI] [PubMed] [Google Scholar]
- 41. Niu H, Kozjak-Pavlovic V, Rudel T, Rikihisa Y. 2010. Anaplasma phagocytophilum Ats-1 is imported into host cell mitochondria and interferes with apoptosis induction. PLoS Pathog 6:e1000774. doi: 10.1371/journal.ppat.1000774 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Xiong Q, Rikihisa Y. 2012. Subversion of NPC1 pathway of cholesterol transport by Anaplasma phagocytophilum. Cell Microbiol 14:560–576. doi: 10.1111/j.1462-5822.2011.01742.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Huang W, Lin M, Rikihisa Y. 2025. Rab27a via its effector JFC1 localizes to Anaplasma inclusions and promotes Anaplasma proliferation in leukocytes. Microbes Infect 27:105278. doi: 10.1016/j.micinf.2023.105278 [DOI] [PubMed] [Google Scholar]
- 44. Imai T, Iwata S, Hirayama T, Nagasawa H, Nakamura S, Shimazawa M, Hara H. 2019. Intracellular Fe2+ accumulation in endothelial cells and pericytes induces blood-brain barrier dysfunction in secondary brain injury after brain hemorrhage. Sci Rep 9:6228. doi: 10.1038/s41598-019-42370-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Hirayama T, Tsuboi H, Niwa M, Miki A, Kadota S, Ikeshita Y, Okuda K, Nagasawa H. 2017. A universal fluorogenic switch for Fe(ii) ion based on N-oxide chemistry permits the visualization of intracellular redox equilibrium shift towards labile iron in hypoxic tumor cells. Chem Sci 8:4858–4866. doi: 10.1039/c6sc05457a [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Arosio P, Ingrassia R, Cavadini P. 2009. Ferritins: a family of molecules for iron storage, antioxidation and more. Biochim Biophys Acta 1790:589–599. doi: 10.1016/j.bbagen.2008.09.004 [DOI] [PubMed] [Google Scholar]
- 47. Kim HY, Rikihisa Y. 1998. Characterization of monoclonal antibodies to the 44-kilodalton major outer membrane protein of the human granulocytic ehrlichiosis agent. J Clin Microbiol 36:3278–3284. doi: 10.1128/JCM.36.11.3278-3284.1998 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Ward DM, Kaplan J. 2012. Ferroportin-mediated iron transport: expression and regulation. Biochim Biophys Acta 1823:1426–1433. doi: 10.1016/j.bbamcr.2012.03.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Rikihisa Y, Zhi N, Wormser GP, Wen B, Horowitz HW, Hechemy KE. 1997. Ultrastructural and antigenic characterization of a granulocytic ehrlichiosis agent directly isolated and stably cultivated from a patient in New York state. J Infect Dis 175:210–213. doi: 10.1093/infdis/175.1.210 [DOI] [PubMed] [Google Scholar]
- 50. Ross SL, Biswas K, Rottman J, Allen JR, Long J, Miranda LP, Winters A, Arvedson TL. 2017. Identification of antibody and small molecule antagonists of ferroportin-hepcidin interaction. Front Pharmacol 8:838. doi: 10.3389/fphar.2017.00838 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Gonçalves AS, Muzeau F, Blaybel R, Hetet G, Driss F, Delaby C, Canonne-Hergaux F, Beaumont C. 2006. Wild-type and mutant ferroportins do not form oligomers in transfected cells. Biochem J 396:265–275. doi: 10.1042/BJ20051682 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Raszeja-Wyszomirska J, Caleffi A, Milkiewicz P, Pietrangelo A. 2014. Ferroportin-related haemochromatosis associated with novel Y64H mutation of the SCL40A1 gene. Prz Gastroenterol 9:307–309. doi: 10.5114/pg.2014.46167 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Schimanski LM, Drakesmith H, Merryweather-Clarke AT, Viprakasit V, Edwards JP, Sweetland E, Bastin JM, Cowley D, Chinthammitr Y, Robson KJH, Townsend ARM. 2005. In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations. Blood 105:4096–4102. doi: 10.1182/blood-2004-11-4502 [DOI] [PubMed] [Google Scholar]
- 54. Bonaccorsi di Patti MC, Polticelli F, Cece G, Cutone A, Felici F, Persichini T, Musci G. 2014. A structural model of human ferroportin and of its iron binding site. FEBS J 281:2851–2860. doi: 10.1111/febs.12825 [DOI] [PubMed] [Google Scholar]
- 55. Majore S, Bonaccorsi di Patti MC, Valiante M, Polticelli F, Cortese A, Di Bartolomeo S, De Bernardo C, De Muro M, Faienza F, Radio FC, Grammatico P, Musci G. 2018. Characterization of three novel pathogenic SLC40A1 mutations and genotype/phenotype correlations in 7 Italian families with type 4 hereditary hemochromatosis. Biochim Biophys Acta Mol Basis Dis 1864:464–470. doi: 10.1016/j.bbadis.2017.11.006 [DOI] [PubMed] [Google Scholar]
- 56. Billesbølle CB, Azumaya CM, Kretsch RC, Powers AS, Gonen S, Schneider S, Arvedson T, Dror RO, Cheng Y, Manglik A. 2020. Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms. Nature 586:807–811. doi: 10.1038/s41586-020-2668-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Kulaksiz H, Gehrke SG, Janetzko A, Rost D, Bruckner T, Kallinowski B, Stremmel W. 2004. Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut 53:735–743. doi: 10.1136/gut.2003.022863 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Pinnix ZK, Miller LD, Wang W, D’Agostino R, Kute T, Willingham MC, Hatcher H, Tesfay L, Sui G, Di X, Torti SV, Torti FM. 2010. Ferroportin and iron regulation in breast cancer progression and prognosis. Sci Transl Med 2:43ra56. doi: 10.1126/scitranslmed.3001127 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Chaudhary S, Ashok A, Wise AS, Rana NA, McDonald D, Kritikos AE, Kong Q, Singh N. 2021. Upregulation of brain hepcidin in prion diseases. Prion 15:126–137. doi: 10.1080/19336896.2021.1946377 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. 2004. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113:1271–1276. doi: 10.1172/JCI20945 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Flannagan RS, Farrell TJ, Trothen SM, Dikeakos JD, Heinrichs DE. 2021. Rapid removal of phagosomal ferroportin in macrophages contributes to nutritional immunity. Blood Adv 5:459–474. doi: 10.1182/bloodadvances.2020002833 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, Simpson RJ. 2000. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5:299–309. doi: 10.1016/s1097-2765(00)80425-6 [DOI] [PubMed] [Google Scholar]
- 63. Canonne-Hergaux F, Donovan A, Delaby C, Wang H, Gros P. 2006. Comparative studies of duodenal and macrophage ferroportin proteins. Am J Physiol Gastrointest Liver Physiol 290:G156–G163. doi: 10.1152/ajpgi.00227.2005 [DOI] [PubMed] [Google Scholar]
- 64. Sabelli M, Montosi G, Garuti C, Caleffi A, Oliveto S, Biffo S, Pietrangelo A. 2017. Human macrophage ferroportin biology and the basis for the ferroportin disease. Hepatology 65:1512–1525. doi: 10.1002/hep.29007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Auriac A, Willemetz A, Canonne-Hergaux F. 2010. Lipid raft-dependent endocytosis: a new route for hepcidin-mediated regulation of ferroportin in macrophages. Haematologica 95:1269–1277. doi: 10.3324/haematol.2009.019992 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Lin M, Rikihisa Y. 2003. Obligatory intracellular parasitism by Ehrlichia chaffeensis and Anaplasma phagocytophilum involves caveolae and glycosylphosphatidylinositol-anchored proteins. Cell Microbiol 5:809–820. doi: 10.1046/j.1462-5822.2003.00322.x [DOI] [PubMed] [Google Scholar]
- 67. Huang W, Xiong Q, Lin M, Rikihisa Y. 2021. Anaplasma phagocytophilum hijacks flotillin and NPC1 complex to acquire intracellular cholesterol for proliferation, which can be inhibited with ezetimibe. mBio 12. doi: 10.1128/mBio.02299-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Shuto T, Furuta T, Cheung J, Gruenert DC, Ohira Y, Shimasaki S, Suico MA, Sato K, Kai H. 2007. Increased responsiveness to TLR2 and TLR4 ligands during dimethylsulfoxide-induced neutrophil-like differentiation of HL-60 myeloid leukemia cells. Leuk Res 31:1721–1728. doi: 10.1016/j.leukres.2007.06.011 [DOI] [PubMed] [Google Scholar]
- 69. Lin M, Rikihisa Y. 2003. Ehrlichia chaffeensis and Anaplasma phagocytophilum lack genes for lipid A biosynthesis and incorporate cholesterol for their survival. Infect Immun 71:5324–5331. doi: 10.1128/IAI.71.9.5324-5331.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Bonitz K, Colucci S, Qiu R, Altamura S, Sparla R, Mudder K, Zimmermann S, Hentze MW, Muckenthaler MU, Marques O. 2025. Hepatocyte Toll-like receptors contribute to the hepcidin inflammatory response to pathogens and pathogen-derived ligands. Hemasphere 9:e70096. doi: 10.1002/hem3.70096 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Wang RH, Li C, Xu X, Zheng Y, Xiao C, Zerfas P, Cooperman S, Eckhaus M, Rouault T, Mishra L, Deng CX. 2005. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab 2:399–409. doi: 10.1016/j.cmet.2005.10.010 [DOI] [PubMed] [Google Scholar]
- 72. Matsuo S, Ogawa M, Muckenthaler MU, Mizui Y, Sasaki S, Fujimura T, Takizawa M, Ariga N, Ozaki H, Sakaguchi M, Gonzalez FJ, Inoue Y. 2015. Hepatocytenuclear factor 4α controls iron metabolism and regulates transferrin receptor 2 in mouse liver. J Biol Chem 290:30855–30865. doi: 10.1074/jbc.M115.694414 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73. Wrighting DM, Andrews NC. 2006. Interleukin-6 induces hepcidin expression through STAT3. Blood 108:3204–3209. doi: 10.1182/blood-2006-06-027631 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74. Lu S, Mott JL, Harrison-Findik DD. 2015. Saturated fatty acids induce post-transcriptional regulation of HAMP mRNA via AU-rich element-binding protein, human antigen R (HuR). J Biol Chem 290:24178–24189. doi: 10.1074/jbc.M115.648212 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont S. 2002. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 110:1037–1044. doi: 10.1172/JCI15686 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76. Kim HY, Rikihisa Y. 2002. Roles of p38 mitogen-activated protein kinase, NF-κB, and protein kinase C in proinflammatory cytokine mRNA expression by human peripheral blood leukocytes, monocytes, and neutrophils in response to Anaplasma phagocytophila. Infect Immun 70:4132–4141. doi: 10.1128/IAI.70.8.4132-4141.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77. Liao Y, Zeng T, Guo X, Li X. 2025. Ferritin’s role in infectious diseases: exploring pathogenic mechanisms and clinical implications. New Microbes New Infect 65:101582. doi: 10.1016/j.nmni.2025.101582 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78. Carlyon JA, Ryan D, Archer K, Fikrig E. 2005. Effects of Anaplasma phagocytophilum on host cell ferritin mRNA and protein levels. Infect Immun 73:7629–7636. doi: 10.1128/IAI.73.11.7629-7636.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79. Ge Y, Rikihisa Y. 2007. Identification of novel surface proteins of Anaplasma phagocytophilum by affinity purification and proteomics. J Bacteriol 189:7819–7828. doi: 10.1128/JB.00866-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80. Xiong Q, Lin M, Rikihisa Y. 2009. Cholesterol-dependent Anaplasma phagocytophilum exploits the low-density lipoprotein uptake pathway. PLoS Pathog 5:e1000329. doi: 10.1371/journal.ppat.1000329 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81. Xiong Q, Lin M, Huang W, Rikihisa Y. 2019. Infection by Anaplasma phagocytophilum requires recruitment of low-density lipoprotein cholesterol by flotillins. mBio 10:e02783-18. doi: 10.1128/mBio.02783-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82. Détivaud L, Nemeth E, Boudjema K, Turlin B, Troadec M-B, Leroyer P, Ropert M, Jacquelinet S, Courselaud B, Ganz T, Brissot P, Loréal O. 2005. Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. Blood 106:746–748. doi: 10.1182/blood-2004-12-4855 [DOI] [PubMed] [Google Scholar]
- 83. Pinto JP, Dias V, Zoller H, Porto G, Carmo H, Carvalho F, de Sousa M. 2010. Hepcidin messenger RNA expression in human lymphocytes. Immunology 130:217–230. doi: 10.1111/j.1365-2567.2009.03226.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84. Gicquel T, Robert S, Loyer P, Victoni T, Bodin A, Ribault C, Gleonnec F, Couillin I, Boichot E, Lagente V. 2015. IL-1β production is dependent on the activation of purinergic receptors and NLRP3 pathway in human macrophages. FASEB J 29:4162–4173. doi: 10.1096/fj.14-267393 [DOI] [PubMed] [Google Scholar]
- 85. Ouhara K, Munenaga S, Kajiya M, Takeda K, Matsuda S, Sato Y, Hamamoto Y, Iwata T, Yamasaki S, Akutagawa K, Mizuno N, Fujita T, Sugiyama E, Kurihara H. 2018. The induced RNA-binding protein, HuR, targets 3’-UTR region of IL-6 mRNA and enhances its stabilization in periodontitis. Clin Exp Immunol 192:325–336. doi: 10.1111/cei.13110 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Fig. S1-S5; Tables S1 and S2.
Data Availability Statement
Data will be made publicly available upon publication and upon request for peer review.








